vs
BioNexus Gene Lab Corp（BGLC）与Natera, Inc.（NTRA）财务数据对比。点击上方公司名可切换其他公司
Natera, Inc.的季度营收约是BioNexus Gene Lab Corp的1375.7倍（$665.5M vs $483.8K）。Natera, Inc.净利率更高（7.1% vs -214.2%，领先221.3%）。Natera, Inc.同比增速更快（39.8% vs -80.8%）。Natera, Inc.自由现金流更多（$37.8M vs $960.1K）。过去两年Natera, Inc.的营收复合增速更高（34.5% vs -54.9%）
BioNexus Gene Lab Corp是一家生物技术企业，主营分子诊断检测、基因分析及相关生命科学解决方案，服务客户涵盖医疗机构、科研机构及个人用户，核心市场主要覆盖东南亚地区。
Natera是总部位于美国得克萨斯州奥斯汀的临床基因检测企业，主打无创游离DNA（cfDNA）检测技术，业务覆盖女性健康、肿瘤及器官健康三大核心赛道。其自研专利技术结合前沿分子生物学手段与生物信息学工具矩阵，可实现单管血液样本中低至单个分子级别的高灵敏度检测。
BGLC vs NTRA — 直观对比
营收规模更大
NTRA
是对方的1375.7倍
$483.8K
营收增速更快
NTRA
高出120.6%
-80.8%
净利率更高
NTRA
高出221.3%
-214.2%
自由现金流更多
NTRA
多$36.9M
$960.1K
两年增速更快
NTRA
近两年复合增速
-54.9%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $483.8K | $665.5M |
| 净利润 | $-1.0M | $47.3M |
| 毛利率 | -0.8% | — |
| 营业利润率 | -213.5% | -3.4% |
| 净利率 | -214.2% | 7.1% |
| 营收同比 | -80.8% | 39.8% |
| 净利润同比 | -197.5% | 187.9% |
| 每股收益（稀释后） | — | $0.36 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BGLCNTRA
| Q4 25 | $483.8K | $665.5M | ||
| Q3 25 | $2.5M | $592.2M | ||
| Q2 25 | $2.3M | $546.6M | ||
| Q1 25 | $2.1M | $501.8M | ||
| Q4 24 | $2.5M | $476.1M | ||
| Q3 24 | $2.6M | $439.8M | ||
| Q2 24 | $2.0M | $413.4M | ||
| Q1 24 | $2.4M | $367.7M |
净利润BGLCNTRA
| Q4 25 | $-1.0M | $47.3M | ||
| Q3 25 | $-709.0K | $-87.5M | ||
| Q2 25 | $-616.2K | $-100.9M | ||
| Q1 25 | $-623.3K | $-66.9M | ||
| Q4 24 | $-348.3K | $-53.8M | ||
| Q3 24 | $-1.3M | $-31.6M | ||
| Q2 24 | $199.1K | $-37.5M | ||
| Q1 24 | $-103.8K | $-67.6M |
毛利率BGLCNTRA
| Q4 25 | -0.8% | — | ||
| Q3 25 | 14.8% | — | ||
| Q2 25 | 16.3% | — | ||
| Q1 25 | 16.1% | — | ||
| Q4 24 | 12.3% | — | ||
| Q3 24 | 12.4% | — | ||
| Q2 24 | 14.6% | — | ||
| Q1 24 | 15.3% | — |
营业利润率BGLCNTRA
| Q4 25 | -213.5% | -3.4% | ||
| Q3 25 | -27.6% | -16.5% | ||
| Q2 25 | -27.0% | -20.2% | ||
| Q1 25 | -28.9% | -15.8% | ||
| Q4 24 | -16.5% | -13.6% | ||
| Q3 24 | -50.9% | -8.9% | ||
| Q2 24 | 13.1% | -10.6% | ||
| Q1 24 | -3.3% | -20.2% |
净利率BGLCNTRA
| Q4 25 | -214.2% | 7.1% | ||
| Q3 25 | -27.9% | -14.8% | ||
| Q2 25 | -27.3% | -18.5% | ||
| Q1 25 | -29.2% | -13.3% | ||
| Q4 24 | -13.8% | -11.3% | ||
| Q3 24 | -51.1% | -7.2% | ||
| Q2 24 | 10.1% | -9.1% | ||
| Q1 24 | -4.4% | -18.4% |
每股收益（稀释后）BGLCNTRA
| Q4 25 | — | $0.36 | ||
| Q3 25 | $-0.40 | $-0.64 | ||
| Q2 25 | $-0.34 | $-0.74 | ||
| Q1 25 | $-0.04 | $-0.50 | ||
| Q4 24 | $0.55 | $-0.41 | ||
| Q3 24 | $-0.75 | $-0.26 | ||
| Q2 24 | $0.11 | $-0.30 | ||
| Q1 24 | $-0.01 | $-0.56 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.5M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $8.6M | $1.7B |
| 总资产 | $9.3M | $2.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BGLCNTRA
| Q4 25 | $2.5M | — | ||
| Q3 25 | — | $1.0M | ||
| Q2 25 | — | $16.0M | ||
| Q1 25 | — | $17.8M | ||
| Q4 24 | $2.9M | $22.7M | ||
| Q3 24 | — | $29.5M | ||
| Q2 24 | — | $90.3M | ||
| Q1 24 | — | $69.1M |
股东权益BGLCNTRA
| Q4 25 | $8.6M | $1.7B | ||
| Q3 25 | $6.8M | $1.3B | ||
| Q2 25 | $7.5M | $1.2B | ||
| Q1 25 | $7.8M | $1.2B | ||
| Q4 24 | $8.3M | $1.2B | ||
| Q3 24 | $9.4M | $878.5M | ||
| Q2 24 | $9.5M | $836.5M | ||
| Q1 24 | $9.3M | $794.1M |
总资产BGLCNTRA
| Q4 25 | $9.3M | $2.4B | ||
| Q3 25 | $7.6M | $1.8B | ||
| Q2 25 | $9.4M | $1.8B | ||
| Q1 25 | $9.5M | $1.7B | ||
| Q4 24 | $10.4M | $1.7B | ||
| Q3 24 | $11.0M | $1.6B | ||
| Q2 24 | $11.1M | $1.5B | ||
| Q1 24 | $11.2M | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $961.1K | $73.9M |
| 自由现金流经营现金流 - 资本支出 | $960.1K | $37.8M |
| 自由现金流率自由现金流/营收 | 198.5% | 5.7% |
| 资本支出强度资本支出/营收 | 0.2% | 5.4% |
| 现金转化率经营现金流/净利润 | — | 1.56× |
| 过去12个月自由现金流最近4个季度 | $-1.9M | $109.1M |
8季度趋势，按日历期对齐
经营现金流BGLCNTRA
| Q4 25 | $961.1K | $73.9M | ||
| Q3 25 | $-1.2M | $59.4M | ||
| Q2 25 | $-737.9K | $37.6M | ||
| Q1 25 | $-824.1K | $44.5M | ||
| Q4 24 | $219.2K | $52.9M | ||
| Q3 24 | $-1.6M | $51.8M | ||
| Q2 24 | $-672.3K | $4.0M | ||
| Q1 24 | $-37.2K | $27.0M |
自由现金流BGLCNTRA
| Q4 25 | $960.1K | $37.8M | ||
| Q3 25 | $-1.2M | $37.0M | ||
| Q2 25 | $-759.4K | $11.7M | ||
| Q1 25 | $-833.1K | $22.6M | ||
| Q4 24 | $215.2K | $34.8M | ||
| Q3 24 | $-1.8M | $35.5M | ||
| Q2 24 | $-674.1K | $-7.7M | ||
| Q1 24 | $-59.1K | $6.7M |
自由现金流率BGLCNTRA
| Q4 25 | 198.5% | 5.7% | ||
| Q3 25 | -48.9% | 6.2% | ||
| Q2 25 | -33.6% | 2.1% | ||
| Q1 25 | -39.0% | 4.5% | ||
| Q4 24 | 8.5% | 7.3% | ||
| Q3 24 | -68.5% | 8.1% | ||
| Q2 24 | -34.1% | -1.9% | ||
| Q1 24 | -2.5% | 1.8% |
资本支出强度BGLCNTRA
| Q4 25 | 0.2% | 5.4% | ||
| Q3 25 | 0.2% | 3.8% | ||
| Q2 25 | 0.9% | 4.7% | ||
| Q1 25 | 0.4% | 4.3% | ||
| Q4 24 | 0.2% | 3.8% | ||
| Q3 24 | 7.6% | 3.7% | ||
| Q2 24 | 0.1% | 2.8% | ||
| Q1 24 | 0.9% | 5.5% |
现金转化率BGLCNTRA
| Q4 25 | — | 1.56× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -3.38× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
